Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020
The European Innovation Council (EIC) has selected the next set of proposals under the 2024 EIC Pathfinder Open call. 45 new projects will receive altogether up to €138 million and will develop cutting-edge technologies throughout a wide range of fields – health, artificial intelligence, computing, environment, and energy.
The successful applications were chosen among 1110 evaluated submissions. Selected applicants come from 25 countries, with the highest number coming from Italy, Germany, Spain and France. Participants mostly come from higher education (46%) and research organisations (22%) and SMEs, accounting for around 22% of participants.
Selected proposals will receive not only grants, but will also have access to tailor-made coaching under the EIC Business Acceleration Services.
2024-12-06
|
2 weeks ago |
Innonext the Next Generation Innovation Talent’s Initiative call open |
2024-12-04
|
2 weeks ago |
The Strategic Technologies for Europe Platform - the STEP funding dashboard with open... |
2024-11-26
|
3 weeks ago |
Webinars for SMEs |
2024-11-26
|
3 weeks ago |
Female entrepreneurs in EU start-ups on the up but still low |
2024-11-05
|
1 month ago |
NCP Flanders team: Reshuffle of responsibilities of our NCP Advisors - Horizon Europe... |
2024-10-21
|
2 months ago |
Temporary suspension of the EIC Accelerator short proposals submissions |
2024-09-23
|
2 months ago |
Number of submitted proposals EIC-transition-open |
2024-07-26
|
4 months ago |
EIC Accelerator – 68 deep-tech start-ups in the latest funding round |
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Horizon Europe Digital Europe Defence
The NCP Flanders team wishes you happy holidays and all the best for 2025! Please note that our offices are closed between Christmas and new year. read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.